Home LiteratureArticle Details
PMID: 17845076 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The inheritance of resistance alleles in multiple sclerosis.

PLoS genetics ·Vol. 3 ·No. 9 ·2007-09-00 ·Pages 1607-13

Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, DeLuca GC, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC

Abstract

Multiple sclerosis (MS) is a complex trait in which alleles at or near the class II loci HLA-DRB1 and HLA-DQB1 contribute significantly to genetic risk. HLA-DRB1*15 and HLA-DRB1*17-bearing haplotypes and interactions at the HLA-DRB1 locus increase risk of MS but it has taken large samples to identify resistance HLA-DRB1 alleles. In this investigation of 7,093 individuals from 1,432 MS families, we have assessed the validity, mode of inheritance, associated genotypes, and the interactions of HLA-DRB1 resistance alleles. HLA-DRB1*14-, HLA-DRB1*11-, HLA-DRB1*01-, and HLA-DRB1*10-bearing haplotypes are protective overall but they appear to operate by different mechanisms. The first type of resistance allele is characterised by HLA-DRB1*14 and HLA-DRB1*11. Each shows a multiplicative mode of inheritance indicating a broadly acting suppression of risk, but a different degree of protection. In contrast, a second type is exemplified by HLA-DRB1*10 and HLA-DRB1*01. These alleles are significantly protective when they interact specifically in trans with HLA-DRB1*15-bearing haplotypes. HLA-DRB1*01 and HLA-DRB1*10 do not interact with HLA-DRB1*17, implying that several mechanisms may be operative in major histocompatibility complex-associated MS susceptibility, perhaps analogous to the resistance alleles. There are major practical implications for risk and for the exploration of mechanisms in animal models. Restriction of antigen presentation by HLA-DRB1*15 seems an improbably simple mechanism of major histocompatibility complex-associated susceptibility.

MeSH Terms
Alleles Genotype HLA Antigens/genetics Haplotypes Humans Linkage Disequilibrium Multiple Sclerosis/genetics
Chemicals
HLA Antigens
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Ramagopalan Sreeram V
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Morris Andrew P
Dyment David A
Herrera Blanca M
DeLuca Gabriele C
Lincoln Matthew R
Orton Sarah M
Chao Michael J
Sadovnick A Dessa
Ebers George C
Conflict of Interest

Competing interests. The authors have declared that no competing interests exist.

References (31)
31 references, click to expand
  1. Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis.
    Mult Scler. 2001 Apr;7(2):91-3 PMID: 11424637
  2. Risk alleles for multiple sclerosis identified by a genomewide study.
    N Engl J Med. 2007 Aug 30;357(9):851-62 PMID: 17660530
  3. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.
    Am J Hum Genet. 2003 Mar;72(3):710-6 PMID: 12557126
  4. New allele frequency database: http://www.allelefrequencies.net.
    Tissue Antigens. 2003 May;61(5):403-7 PMID: 12753660
  5. Twin concordance and sibling recurrence rates in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12877-82 PMID: 14569025
  6. Genetics of multiple sclerosis.
    Lancet Neurol. 2004 Feb;3(2):104-10 PMID: 14747002
  7. Properties of case/pseudocontrol analysis for genetic association studies: Effects of recombination, ascertainment, and multiple affected offspring.
    Genet Epidemiol. 2004 Apr;26(3):186-205 PMID: 15022206
  8. An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: a report from the Canadian Collaborative Study Group.
    Hum Mol Genet. 2004 May 15;13(10):1005-15 PMID: 15069025
  9. Modes of action of HLA-DR susceptibility specificities in multiple sclerosis.
    Am J Hum Genet. 2004 Jun;74(6):1321-2 PMID: 15195659
  10. Evolution of the human HLA-DR region.
    Front Biosci. 1998 Jul 27;3:d739-45 PMID: 9675159
  11. HL-A antigens and multiple sclerosis.
    Lancet. 1972 Jun 3;1(7762):1240-1 PMID: 4113225
  12. Multiple sclerosis: association with HL-A3.
    Tissue Antigens. 1972;2(1):1-4 PMID: 5077731
  13. B-cell alloantigen Ag 7a in multiple sclerosis.
    Lancet. 1975 Oct 25;2(7939):814 PMID: 78174
  14. An HLA-linked immune suppression gene in man.
    J Exp Med. 1980 Aug 1;152(2 Pt 2):297s-313s PMID: 6447747
  15. Studies in familial multiple sclerosis.
    Trans Am Neurol Assoc. 1980;105:344-7 PMID: 6960592
  16. Suppressor T cells control the HLA-linked low responsiveness to streptococcal antigen in man.
    Nature. 1983 Mar 3;302(5903):67-9 PMID: 6219293
  17. Multiple sclerosis: updated risks for relatives.
    Am J Med Genet. 1988 Mar;29(3):533-41 PMID: 3376997
  18. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.
    Tissue Antigens. 1992 May;39(5):225-35 PMID: 1357775
  19. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group.
    Nature. 1995 Sep 14;377(6545):150-1 PMID: 7675080
  20. The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele.
    Tissue Antigens. 1995 Oct;46(4):333-6 PMID: 8560455
  21. A full genome search in multiple sclerosis.
    Nat Genet. 1996 Aug;13(4):472-6 PMID: 8696345
  22. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles.
    Am J Hum Genet. 1997 Aug;61(2):454-7 PMID: 9311753
  23. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group.
    Can J Neurol Sci. 1998 Aug;25(3):216-21 PMID: 9706723
  24. Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive.
    Hum Genet. 2004 Sep;115(4):280-4 PMID: 15300424
  25. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
    Hum Mol Genet. 2005 Jul 15;14(14):2019-26 PMID: 15930013
  26. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis.
    Nat Genet. 2005 Oct;37(10):1108-12 PMID: 16186814
  27. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Hum Mol Genet. 2006 Sep 15;15(18):2813-24 PMID: 16905561
  28. Functional epistasis on a common MHC haplotype associated with multiple sclerosis.
    Nature. 2006 Oct 5;443(7111):574-7 PMID: 17006452
  29. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.
    Nat Genet. 2007 Sep;39(9):1108-13 PMID: 17660816
  30. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Hum Mol Genet. 2007 Aug 15;16(16):1951-8 PMID: 17584771
  31. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes.
    Am J Hum Genet. 2002 Jan;70(1):124-41 PMID: 11719900
Article Info
Journal
PLoS genetics
Abbr.
PLoS Genet
ISSN
1553-7404
Published
2007-09-00
Epub
2007-00-20
Pages
1607-13
Language
English
Region
United States
NLM ID
101239074
PMCID
PMC1971120
Subset
IM
Grants
Wellcome Trust · 081682 · United Kingdom
Multiple Sclerosis Society · 755 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com